Hemab Therapeutics Holdings, Inc. Files 424B4 Prospectus
Ticker: COAG · Form: 424B4 · Filed: May 1, 2026 · CIK: 0002114044
| Field | Detail |
|---|---|
| Company | Hemab Therapeutics Holdings, Inc. (COAG) |
| Form Type | 424B4 |
| Filed Date | May 1, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: prospectus, offering, sec-filing
TL;DR
Hemab Therapeutics Holdings, Inc. filed a prospectus (424B4) on 5/1/2026. Get ready for new shares.
AI Summary
Hemab Therapeutics Holdings, Inc. filed a 424B4 prospectus on May 1, 2026, detailing its intention to offer securities. The filing, with SEC Accession No. 0001193125-26-201458, provides information for potential investors regarding the company's offerings. Hemab Therapeutics Holdings, Inc. is based in Cambridge, MA.
Why It Matters
This filing indicates Hemab Therapeutics Holdings, Inc. is preparing to offer securities to the public, which could signal a future IPO or secondary offering, impacting its capital structure and investor base.
Risk Assessment
Risk Level: medium — A 424B4 filing is a prospectus, often related to an offering of securities, which inherently carries investment risk.
Key Numbers
- 2026-05-01 — Filing Date (Date the 424B4 prospectus was filed and accepted.)
Key Players & Entities
- Hemab Therapeutics Holdings, Inc. (company) — Filer of the prospectus
- 0002114044 (company) — CIK number for Hemab Therapeutics Holdings, Inc.
- 2026-05-01 (date) — Filing date of the 424B4 prospectus
- 0001193125-26-201458 (other) — SEC Accession Number for the filing
- CAMBRIDGE MA 02142 (location) — Mailing and Business Address
FAQ
What type of filing is this 424B4 from Hemab Therapeutics Holdings, Inc.?
This is a 424B4 filing, which is a prospectus filed under Rule 424(b)(4) of the Securities Act of 1933.
When was this 424B4 filing accepted by the SEC?
The filing was accepted on May 1, 2026, at 16:14:08.
What is the CIK number for Hemab Therapeutics Holdings, Inc.?
The CIK number for Hemab Therapeutics Holdings, Inc. is 0002114044.
Where is Hemab Therapeutics Holdings, Inc. located?
Hemab Therapeutics Holdings, Inc. has its mailing and business address at 101 MAIN STREET SUITE 1220 CAMBRIDGE MA 02142.
What is the SEC Accession Number for this filing?
The SEC Accession Number for this filing is 0001193125-26-201458.
Filing Details
This Form 424B4 (Form 424B4) was filed with the SEC on May 1, 2026 regarding Hemab Therapeutics Holdings, Inc. (COAG).